Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differentiating genomics companies.

R James1

  • 1Prelude Technology Investments, Cambridge CB4 5PJ, UK. rob.james@prelude-technology.co.uk

Nature Biotechnology
|February 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal and neonatal outcomes in pregnant patients with Brugada Syndrome - a multicentre retrospective study (2014-2025).

International journal of obstetric anesthesia·2026
Same author

The impact of temperature and skeletal muscle oxygen saturation on 40 km cycling time trial performance of male cyclists.

Physiological reports·2025
Same author

Clinical value of amylase and its prognostic accuracy in guinea pigs (Cavia porcellus).

The Journal of small animal practice·2025
Same author

Sudden cardiac death associated with severe atherosclerosis in a young dog.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2025
Same author

Assessing the appropriateness of antifungal prescribing: key results from the implementation of a novel audit tool in Australian hospitals.

The Journal of antimicrobial chemotherapy·2025
Same author

A retrospective service evaluation of patient awareness and engagement, and medication compliance and adherence, in patients with opportunistically identified vertebral fragility fractures in a local fracture liaison service.

Radiography (London, England : 1995)·2025
Same journal

Author Correction: Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates.

Nature biotechnology·2026
Same journal

Unlocking the chemical potential of filamentous fungi using prime editing.

Nature biotechnology·2026
Same journal

A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

Nature biotechnology·2026
Same journal

Prime editing for precise genome engineering and modulation of fungal metabolism.

Nature biotechnology·2026
Same journal

Retargeted serine integrases for one-step, precise integration of large DNA sequences in human cells.

Nature biotechnology·2026
Same journal

A retargeted recombinase for precise insertion of large DNA.

Nature biotechnology·2026
See all related articles

Genomics companies are shifting from raw data to offering information, therapies, and new technologies. This evolution reflects a changing market value in the genomics sector.

Area of Science:

  • Genomics
  • Biotechnology
  • Bioinformatics

Background:

  • The decreasing value of raw sequence data presents a challenge for genomics companies.
  • The industry is experiencing a transition in its core business models.

Purpose of the Study:

  • To analyze the evolving competencies of genomics companies.
  • To identify new strategic directions in the genomics market.

Main Methods:

  • Review of industry trends and market analysis.
  • Case studies of genomics companies' strategic shifts.

Main Results:

  • Genomics companies are developing expertise beyond data generation.
  • New revenue streams are emerging from information services, therapeutics, and technology innovation.

Related Experiment Videos

Conclusions:

  • The genomics industry is diversifying its offerings to maintain value.
  • Adaptability and innovation are key for future success in genomics.